Sirnaomics
Executives
View the org chart displaying its 16 main executives
Most searched biographies at Sirnaomics
- Patrick Lu, President and Chief Executive Officer
- Mincong Huang, Non-Executive Director
- Fengmao Hua, Independent Non-Executive Director
Popular executive movements at Sirnaomics
- Francois Lebel, who was Senior Vice President, Preclinical and Clinical Development, is promoted to Chief Medical Officer (posted on December 4 2023).
- Michael Molyneaux, Executive Director and Chief Medical Officer, has left the company (posted on December 1 2023).
- Xiaochang Dai, who was Executive Director, Scientific and Strategic Director, is promoted to Chief Strategy Officer (posted on September 1 2023).
Create your alert
to follow the executive moves at Sirnaomics.
Biotechnology
Sirnaomics has 2,285 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Sirnaomics
- Sirnaomics Announces 2023 Annual Results | Sirnaomics
- Sirnaomics will Present its Innovative Dual-Targeted GalNAc muRNA Programs in 2024 OPT Conference | Sirnaomics
- Sirnaomics to Present Latest Developments of STP705 for Focal Fat Reduction at IMCAS World Congress 2024 | Sirnaomics
- Sirnaomics Publishes Novel Mechanism of Action of RNAi Cancer Therapeutic STP707 for Solid Tumors | Sirnaomics
- RNAimmune Receives Investigational New Drug Application Clearance from U.S. FDA for mRNA-Based Respiratory Syncytial Virus Vaccine RV-1770 | Sirnaomics
- Sirnaomics Announces Successful Completion of Cohort 1 from Phase I Clinical Study of GalNAc-Based RNAi Therapeutic STP122G for Anticoagulant Treatment | Sirnaomics
- Sirnaomics Promotes Francois Lebel, M.D. to Chief Medical Officer | Sirnaomics
- Sirnaomics Presents Positive Clinical Data of STP705 for Focal Fat Reduction | Sirnaomics
- Sirnaomics invited to the OASES Partnership Launch Ceremony to become one of the first batch of Strategic Enterprise Partners | Sirnaomics
- Sirnaomics Group Moves into Hong Kong Science Park to Jointly Write a New Chapter for Biomedicine Development | Sirnaomics
- View more press releases Close
Social media about Sirnaomics
- Sirnaomics on Wikipedia, Google News & Yahoo Finance
- Sirnaomics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Patrick Lu 
